Funded startups/BlueWhale Bio, Inc.
BB

BlueWhale Bio, Inc.

SEC filing
Biotechnology · Philadelphia, PA
Form D on EDGAR
Amount raised$5Msold at filing
Total offering$15M$10M still open
Investors in the raise1count reported to the SEC
FiledOct 16, 2025first sale Oct 10, 2025

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Elaine HeronDirector
Peter KellerExecutive Officer, Director
Paul MeisterDirector
Paula CannonDirector
Beate Mueller-TiemannDirector

Executive officers, directors and promoters as listed on the Form D.